Charline Camilla Wurzer is a core member of Boston Consulting Group’s Health Care, Corporate Finance & Strategy, and Global Advantage practices. Charline advises medtech and biopharma clients across Europe, the US, and select emerging markets on growth strategy, next-gen go-to-market models and digital strategy and partnering.
Charline is an author of publications offering insight and guidance to global leaders on topics such as digital ecosystem design, ecosystem governance, and the future of work.
Previously, Charline was a BCG Henderson Institute Ambassador. During that time, she examined the art of collaboration in the digital age and the crucial role that cross-border joint ventures, alliances, and digital ecosystems play in business today. Her research focused on how to set up and manage these new global collaboration networks and use them strategically to gain a competitive edge.
Before joining BCG, Charline worked at J.P. Morgan London on the health care investment banking team, advising clients on IPOs and M&A transactions.
Medical technology companies play a big part in health care’s carbon emissions problem, both at the patient and provider levels. Fortunately, these firms can reduce their footprint affordably.
Companies must attract members and partners to their platforms while maximizing profits.
Many companies are building or joining collaborative networks. The challenge is how to effectively set up and manage these ecosystems and use them strategically to maximize value—and gain a competitive edge.
Joint ventures remain popular as a valuable approach to global business alliances, but with a distinctly new look. Previously, they were viewed primarily as a way to reduce risks or costs, or to expand into new markets. Today’s international joint ventures often involve established and emerging market players—a combination of mature companies and start-ups—joining together to pool their distinctly unique capabilities and resources to create something truly innovative.